Showing 1 to 5 of 5 results
Kennedy to Reform Vaccine Injury Compensation Program
US Health and Human Services Secretary Robert F. Kennedy Jr. announced plans to reform the Vaccine Injury Compensation Program (VICP), citing inefficiency and potential corruption; this follows years of criticism and lawsuits filed by his former organization, Children's Health Defense, and raises co...
Kennedy to Reform Vaccine Injury Compensation Program
US Health and Human Services Secretary Robert F. Kennedy Jr. announced plans to reform the Vaccine Injury Compensation Program (VICP), citing inefficiency and potential corruption; this follows years of criticism and lawsuits filed by his former organization, Children's Health Defense, and raises co...
Progress
52% Bias Score
Merck Stock Plunges 10% on Lower Sales Forecast Amidst China Gardasil Shipment Pause
Merck's stock fell 10% following a lower-than-expected 2025 sales forecast primarily due to a temporary Gardasil vaccine shipment pause to China to address excess inventory and support its Chinese partner amidst slumping sales and a weakening Chinese economy.
Merck Stock Plunges 10% on Lower Sales Forecast Amidst China Gardasil Shipment Pause
Merck's stock fell 10% following a lower-than-expected 2025 sales forecast primarily due to a temporary Gardasil vaccine shipment pause to China to address excess inventory and support its Chinese partner amidst slumping sales and a weakening Chinese economy.
Progress
44% Bias Score
China Approves HPV Vaccine for Males
On January 9th, 2025, China administered its first HPV vaccine dose to a man in Changsha, Hunan province, expanding access to Merck's Gardasil vaccine for males aged 9-26 to prevent HPV-related cancers and genital warts.
China Approves HPV Vaccine for Males
On January 9th, 2025, China administered its first HPV vaccine dose to a man in Changsha, Hunan province, expanding access to Merck's Gardasil vaccine for males aged 9-26 to prevent HPV-related cancers and genital warts.
Progress
36% Bias Score
HPV Vaccine Significantly Reduces Cervical Precancer in Young U.S. Women
A Centers for Disease Control and Prevention report shows an approximately 80% reduction in cervical precancerous cells among 20- to 24-year-old women in the U.S. between 2008 and 2022, strongly correlating with the introduction of the HPV vaccine in 2006.
HPV Vaccine Significantly Reduces Cervical Precancer in Young U.S. Women
A Centers for Disease Control and Prevention report shows an approximately 80% reduction in cervical precancerous cells among 20- to 24-year-old women in the U.S. between 2008 and 2022, strongly correlating with the introduction of the HPV vaccine in 2006.
Progress
52% Bias Score
Kennedy to Retain Financial Stake in Pharma Litigation Despite HHS Nomination
President Trump's nominee for Health and Human Services Secretary, Robert F. Kennedy Jr., will retain financial interests in pharmaceutical litigation, including a 10% contingency fee in cases against Merck regarding Gardasil, even while overseeing drug policy, raising ethical concerns.
Kennedy to Retain Financial Stake in Pharma Litigation Despite HHS Nomination
President Trump's nominee for Health and Human Services Secretary, Robert F. Kennedy Jr., will retain financial interests in pharmaceutical litigation, including a 10% contingency fee in cases against Merck regarding Gardasil, even while overseeing drug policy, raising ethical concerns.
Progress
44% Bias Score
Showing 1 to 5 of 5 results